Skip to Content

Upadacitinib Benefits Ulcerative Colitis Patients – ECCO23 Data

At ECCO23, new data was presented that demonstrated sustained benefits of upadacitinib in achieving symptom resolution and fatigue normalization in patients with active ulcerative colitis.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top